Darwin Global Management as of Dec. 31, 2023
Portfolio Holdings for Darwin Global Management
Darwin Global Management holds 8 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ambrx Biopharma | 46.6 | $238M | 17M | 14.24 | |
| Tg Therapeutics (TGTX) | 13.6 | $69M | 4.0M | 17.08 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 12.3 | $63M | 1.0M | 60.39 | |
| Cytokinetics Com New (CYTK) | 9.8 | $50M | 600k | 83.49 | |
| Keros Therapeutics (KROS) | 8.3 | $42M | 1.1M | 39.76 | |
| Vaxcyte (PCVX) | 7.1 | $36M | 580k | 62.80 | |
| Springworks Therapeutics (SWTX) | 1.4 | $7.0M | 193k | 36.50 | |
| Nuvalent Inc-a (NUVL) | 0.8 | $4.2M | 58k | 73.59 |
